PRICE Act of 2021

The PRICE Act of 2021, also known as Bill 117 hr 6082, is a piece of legislation introduced in the US Congress. The main goal of this bill is to address the rising costs of prescription drugs in the United States.

The PRICE Act aims to increase transparency in the pharmaceutical industry by requiring drug manufacturers to disclose the costs associated with producing and marketing their medications. This information would then be made available to the public, allowing consumers to better understand why certain drugs are priced the way they are.

Additionally, the bill includes provisions to prevent price gouging by pharmaceutical companies. It would require drug manufacturers to justify any price increases that exceed the rate of inflation, and give the government the authority to penalize companies that engage in unfair pricing practices. Furthermore, the PRICE Act seeks to increase competition in the pharmaceutical market by streamlining the approval process for generic drugs. This would help to lower prices for consumers by providing more affordable alternatives to brand-name medications. Overall, the PRICE Act of 2021 aims to address the issue of high prescription drug costs in the United States by increasing transparency, preventing price gouging, and promoting competition in the pharmaceutical industry.